From: Accumulate evidence for IP-10 in diagnosing pulmonary tuberculosis
Author | Year | Country | TB high-burden country | Study design | Age | Number of participants | TB site | Non-TB status | IP-10 cut-off | Reference standard |
---|---|---|---|---|---|---|---|---|---|---|
Zhao Y [7] | 2018 | China | yes | prospective cohort | children and adult | 41 | PTB | healthy controls | not report | A, B |
Zhao Y [7] | 2018 | China | yes | prospective cohort | children and adult | 242 | PTB | healthy controls | not report | A, B |
Zhao Y [7] | 2018 | China | yes | prospective cohort | children and adult | 174 | PTB | healthy controls | not report | A, B |
Blauenfeldt T [13] | 2016 | Denmark | no | prospective cohort | adult | 225 | PTB | healthy controls | 2300 pg/ml | B |
Jacobs R [14] | 2016 | South Africa | yes | prospective cohort | adult | 55 | PTB | non-TB controls (other respiratory diseases) | >  746.6 pg/ml | B |
Lee K [15] | 2015 | Republic of Korea | no | cross-sectional | adult | 457 | PTB | healthy controls | 68.5 pg/ml | A |
Azab NY [16] | 2013 | Egypt | no | prospective cohort | adult | 30 | PTB | healthy controls | not report | B |
Wang X [17] | 2012 | China | yes | cross-sectional | adult | 334 | PTB | healthy controls | 589 pg/ml | A, B/C |
Hong JY [18] | 2012 | Republic of Korea | no | cross-sectional | adult | 78 | PTB | healthy controls | 2811/119.5 pg/ml | A, B |
Kabeer BSA [19] | 2012 | India | yes | retrospective case control | adult | 277 | PTB | healthy controls | not report | A, B |
Luo J [20] | 2018 | China | yes | prospective cohort | adult | 100 | PTB | healthy controls | 631.4 pg/ml | A, B |
Manna MPL [21] | 2018 | Italy | no | retrospective cohort | children and adult | 47 | PTB | non-TB controls (other non-TB pulmonary infections) | >  6557 pg/ml | A, D |
Balcells ME [22] | 2018 | Chile | no | prospective cohort | children and adult | 61 | PTB | household contacts (QFT -) | >  42.6 pg/ml | A, B |
Nonghanphithak D [23] | 2017 | Thailand | yes | prospective cohort | adult | 87 | PTB | healthy controls | 6319, 2372, 6964 pg/ml | A, B, D |
Biraro IA [24] | 2015 | Uganda | yes | prospective cohort | children and adult | 168 | PTB | household contacts (TST and QFT -) | 4858 pg/ml, 0.47 | A |
Wergeland I [25] | 2015 | Norway | no | prospective cohort | adult | 58 | PTB | non-TB controls (HIV-infected) | 2532 pg/ml | A, B |
Petrone L [26] | 2015 | Uganda | yes | prospective cohort | children | 52 | PTB | healthy controls | 209.1 pg/ml | A, B |
Latorre I [27] | 2014 | Spain | no | retrospective cohort | children | 149 | PTB | healthy controls | 2400 pg/ml | A |
Wang S [28] | 2012 | China | yes | cross-sectional | children and adult | 142 | PTB | healthy controls | 451.3 pg/ml | A, B |
Jeong YH [29] | 2015 | Republic of Korea | no | cross-sectional | adult | 59 | PTB | healthy controls | 0.7906 | A, C |